JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms

Giraldo-Rincón, Ana Isabel; Naranjo Molina, Sara; Gomez-Lopera, Natalia; Aguirre Acevedo, Daniel; Ucroz Benavidez, Andrea; Gálvez Cárdenas, Kenny; Cuellar Ambrosí, Francisco; Torres, Jose Domingo; Ospina, Sigifredo; Palacio, Katherine; Gaviria Jaramillo, Lina; Muñeton, Carlos Mario; Vasquez Palacio, Gonzalo.
Colomb. med ; 54(3)sept. 2023.
Artículo en Inglés | LILACS-Express | ID: biblio-1534294

Documentos relacionados

  1. JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.
  2. Genetic alterations in patients with chronic leucocytosis and persistent thrombocytosis.
  3. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
  4. [Erythrocytosis following allogeneic hematopoietic stem cell transplantation].
  5. Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype.
  6. [Erythrocytosis after hematopoietic stem cell transplantation: report of 3 cases and literature review].
  7. Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients.
  8. Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications.
  9. Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model.
  10. Genetic basis and molecular profiling in myeloproliferative neoplasms.